Aclaris Therapeutics, Inc. (ACRS)
NASDAQ: ACRS · Real-Time Price · USD
1.810
+0.010 (0.56%)
Oct 31, 2024, 4:00 PM EDT - Market closed

Aclaris Therapeutics Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2014
Period Ending
Jun '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2014
Operating Revenue
32.0231.2529.56.646.484.23
Upgrade
Other Revenue
--0.260.120.01-
Upgrade
Revenue
32.0231.2529.756.766.484.23
Upgrade
Revenue Growth (YoY)
2.72%5.03%340.05%4.30%53.35%-31.28%
Upgrade
Cost of Revenue
87.5116.4789.7748.5334.4768.22
Upgrade
Gross Profit
-55.48-85.22-60.02-41.77-27.99-63.99
Upgrade
Selling, General & Admin
26.932.4125.1323.6220.5327.83
Upgrade
Operating Expenses
26.932.4125.1323.6220.5327.83
Upgrade
Operating Income
-82.38-117.63-85.15-65.38-48.52-91.82
Upgrade
Interest & Investment Income
8.518.51----
Upgrade
Other Non Operating Income (Expenses)
-0.15-2.95-1.14-0.42-2.48
Upgrade
EBT Excluding Unusual Items
-74.02-109.12-82.21-66.53-48.94-94.3
Upgrade
Impairment of Goodwill
------18.5
Upgrade
Other Unusual Items
21.626.9-4.7-24.34-2.39-0.73
Upgrade
Pretax Income
-59.05-88.85-86.91-90.87-51.34-113.54
Upgrade
Income Tax Expense
-0.37-0.37---0.18-
Upgrade
Earnings From Continuing Operations
-58.68-88.48-86.91-90.87-51.15-113.54
Upgrade
Earnings From Discontinued Operations
----0.14-47.81
Upgrade
Net Income
-58.68-88.48-86.91-90.87-51.02-161.35
Upgrade
Net Income to Common
-58.68-88.48-86.91-90.87-51.02-161.35
Upgrade
Shares Outstanding (Basic)
717065574341
Upgrade
Shares Outstanding (Diluted)
717065574341
Upgrade
Shares Change (YoY)
4.85%7.05%14.95%33.36%2.94%25.57%
Upgrade
EPS (Basic)
-0.83-1.27-1.33-1.60-1.20-3.90
Upgrade
EPS (Diluted)
-0.83-1.27-1.33-1.60-1.20-3.90
Upgrade
Free Cash Flow
-65.1-79.63-68.17-52.44-39.09-98.06
Upgrade
Free Cash Flow Per Share
-0.92-1.14-1.05-0.92-0.92-2.37
Upgrade
Gross Margin
-173.29%-272.70%-201.74%---
Upgrade
Operating Margin
-257.32%-376.42%-286.21%-967.08%-748.52%-2172.23%
Upgrade
Profit Margin
-183.29%-283.15%-292.11%-1343.96%-787.03%-3817.22%
Upgrade
Free Cash Flow Margin
-203.35%-254.84%-229.13%-775.65%-602.99%-2319.80%
Upgrade
EBITDA
-82.15-117.57--65.06-48.2-90.84
Upgrade
D&A For EBITDA
0.230.06-0.320.320.98
Upgrade
EBIT
-82.38-117.63-85.15-65.38-48.52-91.82
Upgrade
EBIT Margin
-257.32%--286.21%---
Upgrade
Revenue as Reported
32.0231.2529.756.766.484.23
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.